Is Climb Bio, Inc. (CLYM) a Buy, Sell, or Hold?
Climb Bio, Inc.
NASDAQ:CLYM
$13.87 USD
$0.63 (4.76%)
- Volume
- 969.59K
- Average Volume
- 1.19M
- Market Capitalization
- $945.72M
- P/E Ratio
- -17.78
- Dividend Yield
- 0.00%
- Price Target
- $20.00
- Year High
- $14.42
- Year Low
- $1.36
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $27.86
Analyst Rating
Sell
2 Rating Score
UPSIDE/DOWNSIDE
-30.7% DOWNSIDE
$20.00 Price Target
UPSIDE/DOWNSIDE HIGH
-60.4% DOWNSIDE
$35.00 Price Target High
UPSIDE/DOWNSIDE LOW
-18.4% DOWNSIDE
$17.00 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| BTIG | Julian Harrison | $20 | $11.17 | 2026-06-11 12:20 PM | 79.1% |
| H.C. Wainwright | Raghuram Selvaraju | $20 | $11.12 | 2026-05-12 06:13 AM | 79.9% |
| Mizuho Securities | Joseph Catanzaro | $18 | $8.85 | 2026-04-15 04:47 AM | 103.4% |
| Truist Financial | Danielle Brill | $17 | $7.12 | 2026-03-17 04:06 PM | 138.8% |
| Raymond James | Christopher Raymond | $25 | $7.33 | 2026-03-10 04:06 PM | 241.1% |
| H.C. Wainwright | Raghuram Selvaraju | $11 | $4.25 | 2025-12-18 06:06 AM | 158.8% |